Although the application of anti-vascular endothelial growth factor injections has made significant progression in the therapy of neovascular AMD (nAMD, a form of advanced AMD), many patients did not benefit much due to individual differences and no treatment was effective for early AMD [3, 4]. The gene discussed is VEGFA; the disease is age-related macular degeneration.